Evidence map›Paper›PMID 42908680›Full record

ArticleFrontiers in medicine2026

Machine learning model for ACLF risk in decompensated cirrhosis.

Liwen Chen, Peipei Ren, Yi Kang

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Liwen ChenDepartment of Infectious Diseases, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, China.
Peipei RenDepartment of Infectious Diseases, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, China.
Yi KangDepartment of Infectious Diseases, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To develop a machine learning-based predictive model for acute-on-chronic liver failure (ACLF) risk in patients with decompensated cirrhosis using baseline clinical indicators at hospital admission. Materials and methods: This retrospective cohort included 360 decompensated cirrhosis patients with intensive monitoring needs or infection/circulatory risk factors, randomly divided into training and validation sets at a 7:3 ratio. Three models-random forest, support vector machine, and logistic regression-were constructed. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA). SHapley Additive exPlanations (SHAP) were employed for model interpretability. Results: In the training set, 52 patients (20.6%) experienced ACLF. Multivariate analysis identified total bilirubin (TBil) (OR = 1.051, 95% CI: 1.030-1.073, Conclusion: The random forest model showed acceptable training performance, but the wide validation AUC confidence interval suggests limited stability, likely due to small sample size and few events. External validation is needed before clinical use. Nonetheless, the model shows potential for early warning and risk stratification in decompensated cirrhosis.

Indexed as

acute-on-chronic liver failuredecompensated cirrhosislactatemachine learningnomogramprediction modelrandom forestSHAP

Identifiers

PMID42908680
PMCPMC13683224

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.